NYSE : LLY

Eli Lilly and Company — Financial statements

Healthcare · Drug Manufacturers - General · United States

Last price 1373.7 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 1.22T

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Financial statements

Eli Lilly and Company (LLY) reported revenue of 86.46B USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.

Income statement

Fiscal year January - December; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Revenue86.46B65.18B45.04B34.12B28.54B28.32B
Cost of Revenue14.15B11.05B8.42B7.08B6.63B6.97B
Gross Profit72.31B54.13B36.62B27.04B21.91B21.35B
Selling, General & Admin12.62B11.09B8.59B7.40B6.07B6.14B
Research & Development15.38B13.34B10.99B9.31B7.19B6.93B
Operating Expenses28.00B24.43B19.59B16.72B13.26B13.07B
Operating Income44.31B29.70B17.04B10.32B8.65B8.27B
Interest Expense-383.00M-331.60M-339.80M
Interest & Investment Income62.80M25.40M
Currency Exchange Gain (Loss)481.00M-191.30M-204.60M
Other Non Operating Income (Expenses)-205.00M-571.00M-219.00M97.00M177.00M256.00M
EBT Excluding Unusual Items44.21B29.12B16.82B10.42B8.37B8.01B
Merger & Restructuring Charges-13.00M
Gain (Loss) on Sale of Investments-410.70M176.90M
Other Unusual Items-1.37B-484.00M-861.00M-68.00M-244.60M-1.05B
Pretax Income34.77B25.73B12.68B6.55B6.81B6.16B
Income Tax Expense7.19B5.09B2.09B1.31B561.60M573.80M
Earnings From Continuing Operations27.58B20.64B10.59B5.24B6.24B5.58B
Net Income27.58B20.64B10.59B5.24B6.24B5.58B
Net Income to Common27.58B20.64B10.59B5.24B6.24B5.58B
Shares Outstanding (Basic)893.62M897.30M900.60M900.20M901.74M906.96M
Shares Outstanding (Diluted)895.33M899.30M904.10M903.30M904.62M911.68M
EPS (Basic)30.8623.0011.765.826.936.15
EPS (Diluted)30.8122.9511.715.806.906.12
Free Cash Flow19.66B8.97B3.76B792.00M5.73B6.06B
Free Cash Flow Per Share21.969.984.160.886.346.64
Dividend Per Share6.696.005.204.523.923.40
Gross Margin83.63%83.04%81.31%79.25%76.77%75.38%
Operating Margin51.25%45.56%37.83%30.26%30.32%29.21%
Profit Margin31.90%31.67%23.51%15.36%21.88%19.71%
Free Cash Flow Margin22.74%13.76%8.35%2.32%20.08%21.39%
EBITDA46.49B31.69B18.81B11.85B10.18B9.82B
EBITDA Margin53.77%48.62%41.75%34.73%35.65%34.68%
D&A For EBITDA2.17B2.00B1.77B1.53B1.52B1.55B
EBIT44.31B29.70B17.04B10.32B8.65B8.27B
EBIT Margin51.25%45.56%37.83%30.26%30.32%29.21%
Effective Tax Rate20.68%19.79%16.48%20.05%8.25%9.32%
Advertising Expenses966.80M1.24B

Balance sheet

Fiscal year January - December; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Cash & Equivalents4.88B7.27B3.27B2.82B2.07B3.82B
Short-Term Investments109.10M144.80M90.10M
Trading Asset Securities113.80M230.50M4.80M
Cash & Short-Term Investments4.88B7.27B3.27B3.04B2.44B3.91B
Accounts Receivable22.09B17.76B11.01B9.09B6.90B6.67B
Other Receivables3.14B2.36B1.93B2.00B1.41B1.44B
Receivables25.23B20.12B12.94B11.09B8.30B8.11B
Inventory18.19B13.74B7.59B5.77B4.31B3.89B
Prepaid Expenses16.86B1.42B1.24B5.54B2.95B2.53B
Other Current Assets91.00M13.09B7.70B279.10M33.90M9.90M
Total Current Assets65.26B55.63B32.74B25.73B18.03B18.45B
Property, Plant & Equipment32.19B25.93B18.15B13.94B10.14B8.99B
Long-Term Investments4.01B2.80B3.22B3.41B3.20B3.40B
Goodwill9.87B5.90B5.77B4.94B4.07B3.89B
Other Intangible Assets18.08B6.52B6.17B6.91B7.21B7.69B
Long-Term Deferred Tax Assets10.96B9.96B8.00B5.48B2.79B2.49B
Other Long-Term Assets7.70B5.73B4.67B3.61B4.04B3.89B
Total Assets148.07B112.48B78.72B64.01B49.49B48.81B
Accounts Payable5.79B5.38B3.23B2.60B1.93B1.67B
Accrued Expenses26.46B19.76B13.63B13.42B9.92B7.88B
Short-Term Debt4.34B6.19B1.50B
Current Portion of Long-Term Debt2.52B1.64B779.00M745.90M3.10M1.54B
Current Portion of Leases222.00M176.00M156.30M
Current Income Taxes Payable126.90M
Other Current Liabilities12.22B8.23B6.22B4.18B3.78B3.84B
Total Current Liabilities47.00B35.23B28.38B27.29B17.14B15.05B
Long-Term Debt46.99B40.87B28.53B18.42B14.87B15.39B
Long-Term Leases1.14B971.00M948.50M
Pension & Post-Retirement Benefits1.44B1.31B1.95B
Long-Term Deferred Tax Liabilities1.73B
Other Long-Term Liabilities13.82B8.71B6.57B5.04B5.40B5.52B
Total Liabilities107.80B85.94B64.44B53.14B38.71B39.65B
Common Stock588.00M590.00M592.00M593.60M594.10M596.30M
Additional Paid-In Capital7.31B7.35B7.44B7.25B6.92B6.83B
Retained Earnings37.97B24.47B13.54B10.31B10.04B8.96B
Treasury Stock-44.20M-50.50M-52.70M
Comprehensive Income & Other-5.59B-5.87B-7.30B-7.34B-6.86B-7.36B
Total Common Equity40.27B26.54B14.27B10.77B10.65B8.98B
Minority Interest91.80M125.60M175.60M
Shareholders' Equity40.27B26.54B14.27B10.86B10.78B9.15B
Total Liabilities & Equity148.07B112.48B78.72B64.01B49.49B48.81B
Total Debt49.50B43.87B34.79B26.46B16.37B16.93B
Net Cash (Debt)-43.86B-36.37B-31.04B-22.71B-13.25B-11.73B
Net Cash Per Share-48.99-40.45-34.33-25.14-14.64-12.87
Filing Date Shares Outstanding890.75M893.36M898.17M900.16M900.30M902.35M
Total Common Shares Outstanding891.20M894.80M897.54M899.38M900.18M903.65M
Working Capital18.27B20.40B4.36B-1.57B896.30M3.40B
Book Value Per Share45.1929.6515.9011.9811.839.94
Tangible Book Value12.31B14.12B2.34B-1.07B-629.80M-2.60B
Tangible Book Value Per Share13.8215.782.60-1.19-0.70-2.88
Land647.00M382.00M319.80M256.60M258.70M
Buildings10.09B8.81B8.28B7.92B7.59B
Machinery13.49B11.46B10.33B9.41B8.94B
Construction In Progress13.01B8.24B5.08B2.80B2.18B

Cash flow statement

Fiscal year January - December; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Net Income27.58B20.64B10.59B5.24B6.24B5.58B
Depreciation & Amortization2.17B2.00B1.77B1.53B1.52B1.55B
Loss (Gain) From Sale of Assets-180.00M-180.00M-224.00M-1.88B-156.50M-216.00M
Asset Writedown & Restructuring Costs8.07B2.91B3.28B3.80B908.50M970.10M
Loss (Gain) From Sale of Investments420.00M-178.00M
Stock-Based Compensation698.00M626.00M646.00M629.00M371.10M342.80M
Other Operating Activities-2.12B-1.09B-1.86B-2.02B-1.72B330.30M
Change in Accounts Receivable-7.00B-7.00B-2.15B-2.45B-299.60M-1.28B
Change in Inventory-4.67B-4.67B-2.51B-1.43B-599.70M-235.90M
Change in Accounts Payable10.19B10.19B2.61B4.27B1.69B-1.01B
Change in Other Net Operating Assets-4.09B-6.61B-3.33B-3.45B-793.50M1.52B
Operating Cash Flow30.64B16.81B8.82B4.24B7.59B7.37B
Capital Expenditures-10.98B-7.84B-5.06B-3.45B-1.85B-1.31B
Cash Acquisitions-10.80B-661.00M-948.00M-1.04B-327.20M-747.40M
Sale (Purchase) of Intangibles-7.75B-2.79B-2.75B-2.34B-1.04B-452.60M
Investment in Securities-25.00M319.00M-303.00M-223.00M-244.00M-166.00M
Other Investing Activities-847.00M1.00M-248.00M-98.00M-302.20M-191.70M
Investing Cash Flow-30.41B-10.97B-9.30B-7.15B-3.76B-2.87B
Short-Term Debt Issued4.69B1.50B
Long-Term Debt Issued13.17B11.42B3.96B2.41B
Total Debt Issued8.94B13.17B11.42B8.65B1.50B2.41B
Short-Term Debt Repaid-4.34B-1.85B-4.00M
Long-Term Debt Repaid-778.00M-664.00M-1.56B-1.91B
Total Debt Repaid-1.62B-5.12B-2.52B-1.56B-1.91B
Net Debt Issued (Repaid)7.32B8.05B8.90B8.65B-62.00M501.40M
Repurchase of Common Stock-5.84B-4.11B-2.50B-750.00M-1.50B-1.25B
Common Dividends Paid-5.98B-5.38B-4.68B-4.07B-3.54B-3.09B
Other Financing Activities-638.00M-772.00M-491.00M-335.00M-308.90M-295.90M
Financing Cash Flow-5.14B-2.21B1.23B3.50B-5.41B-4.13B
Foreign Exchange Rate Adjustments4.00M372.00M-297.00M169.00M-167.60M-205.70M
Net Cash Flow-4.91B4.00B449.00M752.00M-1.75B161.40M
Free Cash Flow19.66B8.97B3.76B792.00M5.73B6.06B
Free Cash Flow Margin22.74%13.76%8.35%2.32%20.08%21.39%
Free Cash Flow Per Share21.969.984.160.886.346.64
Levered Free Cash Flow9.34B1.95B1.35B292.32M5.28B5.46B
Unlevered Free Cash Flow9.58B1.95B1.35B292.32M5.48B5.67B
Cash Interest Paid633.00M633.00M578.00M404.00M323.70M338.00M
Cash Income Tax Paid10.81B10.81B6.56B5.56B2.67B1.60B
Change in Working Capital-5.57B-8.09B-5.38B-3.06B-800.00K-1.01B

Ratios

Fiscal year January - December; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Market Capitalization1.26T962.25B695.13B524.22B347.61B250.42B
Enterprise Value1.30T994.65B722.37B541.49B360.38B262.42B
Last Close Price1,410.991,069.51762.60572.09355.54264.82
PE Ratio45.7946.6265.64100.0455.6644.86
Forward PE30.3634.3335.1353.3746.2731.77
PS Ratio14.5414.7615.4315.3612.188.84
PB Ratio31.2336.2648.7148.2632.2627.35
P/TBV Ratio102.0768.17297.57
P/FCF Ratio63.93107.25184.88661.9060.6541.35
P/OCF Ratio41.0157.2378.83123.6445.8334.00
PEG Ratio1.461.070.932.512.542.20
EV/Sales Ratio15.0415.2616.0415.8712.639.27
EV/EBITDA Ratio27.9831.3838.4145.6935.4126.72
EV/EBIT Ratio29.3533.4942.3952.4441.6531.72
EV/FCF Ratio66.16110.86192.12683.7062.8843.33
Debt / Equity Ratio1.231.652.442.441.521.85
Debt / EBITDA Ratio1.061.371.832.201.611.72
Debt / FCF Ratio2.524.899.2533.412.862.79
Net Debt / Equity Ratio1.091.372.172.091.231.28
Net Debt / EBITDA Ratio0.941.151.651.921.301.20
Net Debt / FCF Ratio2.234.058.2628.682.311.94
Asset Turnover0.660.680.630.600.580.59
Inventory Turnover0.931.041.261.411.621.77
Quick Ratio0.640.780.570.520.630.80
Current Ratio1.391.581.150.941.051.23
Return on Equity (ROE)86.02%101.16%84.26%48.43%62.67%74.52%
Return on Assets (ROA)21.06%19.41%14.92%11.37%11.00%10.84%
Return on Invested Capital (ROIC)42.68%43.74%35.54%27.99%33.88%36.42%
Return on Capital Employed (ROCE)43.80%38.40%33.90%28.10%26.70%24.50%
Earnings Yield2.18%2.15%1.52%1.00%1.80%2.23%
FCF Yield1.56%0.93%0.54%0.15%1.65%2.42%
Dividend Yield0.49%0.56%0.67%0.78%1.01%1.23%
Payout Ratio22.46%26.09%44.19%77.65%56.62%55.30%
Buyback Yield / Dilution0.58%0.53%-0.09%0.15%0.78%0.09%
Total Shareholder Return1.07%1.09%0.58%0.92%1.79%1.32%